ABPI statement on BGMA legal action over Voluntary Scheme negotiation representation
The British Generic Manufacturers Association (BGMA) is seeking a judicial review of the Department of Health and Social Care’s (DHSC) decision to negotiate a new Voluntary Scheme for branded…
Read the full articleYou might also wanna read
Why the government must urgently raise the NICE cost-effectiveness threshold
ABPI·2d ago
Understanding NHS medicines spending in England
ABPI·2d ago
ABPI response to Life Sciences Competitiveness Indicators
ABPI·2d ago
Updates to the NHS Commercial Framework must deliver more flexibility to support timely access to medicines
ABPI·3d ago
Disclosure UK 2025: the 11th year of Disclosure UK data, with industry transparency continuing to grow
ABPI·3d ago
Package deals in the pharmaceutical industry and Disclosure UK data
ABPI·3d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.